Amedisys Inc. buy Royal Bank of Canada
Start price
16.04.25
/
50%
€79.50
Target price
16.04.26
€88.29
Performance (%)
6.92%
End price
17.04.26
-
Summary
This prediction is currently being closed. With a performance of 6.92%, the BUY prediction by Royal_Bank_of_Canada for Amedisys Inc. is trending in the right direction. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Amedisys Inc. | - | - | - |
| iShares Core DAX® | -1.424% | 8.918% | 7.311% |
| iShares Nasdaq 100 | 3.274% | 16.275% | 36.651% |
| iShares Nikkei 225® | 1.745% | 16.239% | 46.602% |
| iShares S&P 500 | 1.447% | 10.913% | 27.166% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Amedisys Inc. diskutieren
Amedisys, Inc. (NASDAQ: AMED) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $100.00 price target on the stock.
Ratings data for AMED provided by MarketBeat
In the thread Trading Amedisys Inc.
Die von Royal_Bank_of_Canada gewählte maximale Laufzeit wurde überschritten